Behavioral Activation for Opioid Use Disorder

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-30

Study Completion Date

2023-02-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall purpose of this pilot study is to evaluate the feasibility and acceptability of values-based behavioral activation (BA) as an adjunct intervention for patients receiving medications for opioid use disorder (OUD) in primary care. Researcher will evaluate the following aims: 1) examine the feasibility of BA for OUD in primary care, 2) examine whether the BA intervention and study requirements are acceptable to participants, and 3) determine the psychometric properties of the outcome measures in people with OUD. Participants will complete 4-6 brief counseling sessions over the course of 12 weeks. During the first session, participants will discuss values and recovery outcomes important to them. Next, they will set 2-3 personal goals to work on before the next BA session. At the follow-up sessions, participants will update the counselor on progress made or challenges experienced. Personal values will be reviewed and participant goals updated. Study measures (surveys and urine drug tests) will be completed at the start, partway through, and at the end of the intervention.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder

NCT04257214

Opioid Use Disorder

ACTIVE_NOT_RECRUITING NA

Peer-Delivered Behavioral Activation for Methadone Adherence - Pilot Phase

NCT04248933

Substance Use Substance Use Disorders Opioid-use Disorder +5 more

COMPLETED NA

Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

NCT05288751

Opioid Use Disorder Stimulant Use Disorder

ACTIVE_NOT_RECRUITING NA

Therapy for People With Opioid Use Disorder

NCT06008769

Opioid Use Disorder

ACTIVE_NOT_RECRUITING NA

CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder

NCT04240093

Opioid-use Disorder Medication Adherence Health Care Utilization

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

single-arm, pre/post pilot trial

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Values-based Behavioral Activation (BA)

Group Type EXPERIMENTAL

Values-based Behavioral Activation

Intervention Type BEHAVIORAL

Initially, patients complete a values assessment in which they identify personal values in various life domains. With the assistance of a clinician, patients set incremental behavior goals to move their daily actions to better align with their self-reported values. Goal completion allows the patient to achieve outcomes consistent with recovery, and they potentially experience enjoyment, self-efficacy, and confidence as they progress through the treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Values-based Behavioral Activation

Initially, patients complete a values assessment in which they identify personal values in various life domains. With the assistance of a clinician, patients set incremental behavior goals to move their daily actions to better align with their self-reported values. Goal completion allows the patient to achieve outcomes consistent with recovery, and they potentially experience enjoyment, self-efficacy, and confidence as they progress through the treatment.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 18 years of age.
* Diagnosis of opioid use disorder.
* Have an active prescription for buprenorphine-naloxone (Suboxone) for at least one month.
* Patient at Broadway Family Medicine (BFM)

Exclusion Criteria

* Concurrent individual psychotherapy with a psychologist or counselor at least monthly
* Active suicidal ideation (intention, plan, or attempt in the past 30 days, as determined by chart review)
* Dementia, developmental disabilities, or cognitive functioning that is too low to participate in therapy, as determined by chart review

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No